VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A phase I/II study combining erlotinib and dasatinib for non-small cell lung cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A phase I/II study combining erlotinib and dasatinib for non-small cell lung cancer.
A phase I/II study combining erlotinib and dasatinib for non-small cell lung cancer. Oncologist. 2014 Oct; 19(10):1040-1.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Biomarkers, Tumor
Carcinoma, Non-Small-Cell Lung
Dasatinib
ErbB Receptors
Erlotinib Hydrochloride
Humans
Lung Neoplasms
Maximum Tolerated Dose
src-Family Kinases
Treatment Outcome
authors with profiles
FAYE M JOHNSON
GEORGE R BLUMENSCHEIN
JEREMY J ERASMUS
IGNACIO IVAN WISTUBA